fashion -WSS

fashion

author：focus 2025-10-01 00:06:14 - browse：51228

Drugmakers already bet big on mRNA for cancer. Now President Biden is going in, too? Anna Moneymaker/Getty Images

WASHINGTON — President Biden’s fledgling health agency, designed to accelerate under-funded research, just set its sights on one of the hottest areas of medicine — and one where the drug industry has a multibillion-dollar head start.

The White House announced Wednesday that the Advanced Research Projects Agency for Health would bankroll a $24 million project by Emory University to build messenger RNA platforms to target “cancer and other diseases,” investing in the technology behind the U.S.’s most commonly used vaccines for Covid-19.

The administration touted the news of CUREIT as the latest in Biden’s longtime mission to rein in cancer deaths, the Cancer Moonshot. But by using mRNA to treat cancer, ARPA-H is wading into a field that has advanced in fits and starts — and whose industry leaders have already spent multiples of the program’s entire budget into their own research. Moderna and BioNTech, massively profitable companies that have sold more than $80 billion worth of Covid-19 vaccines combined, have singled out oncology as the next big application for mRNA and invested accordingly.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

Wikipedia

WSS

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Superbugs, antibiotic resistance get scrutiny in congress

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Antibody drugs appear effective. Now can we make enough of them?

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

entertainment

fashion

hotspot

Psychedelics group wrestles with new pharma identity

Travis Kelce and the trap of celebrity vaccine endorsements

As demand for Covid shots wanes, Moderna seeks its next success

Prime Medicine says its gene editing passes test in monkeys

Psychedelics group wrestles with new pharma identity

Gene therapy’s promise and the high cost of hope

Walensky prepares to leave CDC — and Congress — behind

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

Sports medicine is finally prioritizing gender equality

After Sarepta trial failure, Duchenne families brace for more debate

Wikipedia

France's anti

Travis Kelce and the trap of celebrity vaccine endorsements

Grail's uphill battle for Medicare to cover its cancer screening test

China sends large group of warplanes, navy ships towards Taiwan in forceful display

Life sciences investors close nearly $6 billion in new funds

Bill would allow buprenorphine prescription for addiction via telehealth

explore

focus

Wikipedia

Wikipedia